The cause of ovarian hyperstimulation syndrome isn't fully understood, although having a high level of human chorionic gonadotropin (HCG) — a hormone usually produced during pregnancy — in your system plays a role. Ovarian blood vessels react abnormally to HCG and begin to leak fluid. This fluid swells the ovaries, and sometimes large amounts move into the abdomen.
During fertility treatments, HCG may be given as a "trigger" so that a mature follicle will release its egg. OHSS usually happens within a week after you receive an HCG injection. If you become pregnant during a treatment cycle, OHSS may worsen as your body begins producing its own HCG in response to the pregnancy.
Injectable fertility medications are more likely to cause OHSS than is treatment with clomiphene (Clomid, Serophene), a medication given as a pill you take by mouth.
Feb. 14, 2014
- Gera PS, et al. Ovarian hyperstimulation syndrome: Steps to maximize success and minimize effect for assisted reproductive outcome. Fertility and Sterility. 2010;94:173.
- Insler V, et al. Pathogenesis of ovarian hyperstimulation syndrome. http://www.uptodate.com/home Accessed Sept. 23, 2013.
- Shaw RW, et al. Gynaecology. 4th ed. Edinburgh, U.K.: Churchill Livingstone; 2011. http://www.clinicalkey.com. Accessed Sept. 24, 2013.
- Vloeberghs V, et al. Ovarian hyperstimulation syndrome and complications of ART. Best Practice & Research Clinical Obstetrics and Gynaecology. 2009;23:691.
- Insler V, et al. Classification and treatment of ovarian hyperstimulation syndrome. http://www.uptodate.com/home. Accessed Sept. 23, 2013.
- Lentz GM, et al. Comprehensive Gynecology. 6th ed. Philadelphia, Pa.: Mosby Elsevier; 2012. http://www.clinicalkey.com. Accessed Sept. 24, 2013.
- Luke B, et al. Factors associated with ovarian hyperstimulation syndrome (OHSS) and its effect on assisted reproductive technology (ART) treatment and outcome. Fertility and Sterility. 2010;94:1399.
- Adams JG. Emergency Medicine: Clinical Essentials. 2nd ed. Philadelphia, Pa. Saunders Elsevier; 2013. http://www.clinicalkey.com. Accessed Sept. 24, 2013.
- Insler V, et al. Prevention of ovarian hyperstimulation syndrome. http://www.uptodate.com/home. Accessed Sept. 23, 2013.
- Practice Committee of the American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertility and Sterility. 2006;86:S178.
- Coddington CC (expert opinion). Mayo Clinic, Rochester, Minn. Oct. 2, 2013.
- Rollene NL, et al. Treatment of ovarian hyperstimulation syndrome using a dopamine agonist and gonadotropin releasing hormone antagonist: A case series. Fertility and Sterility. 2009;92:1169.e15.